A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib (TRAVERSE)

Clinical Trial ID NCT01387555

PubWeight™ 18.07^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01387555

Top papers